ClonOrgan Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series A3

  • Latest Deal Amount
  • $29.5M

  • Investors
  • 13

ClonOrgan General Information

Description

Developer of gene-edited donor pigs designed for xenotransplantation. The company utilizes gene editing and somatic cell nuclear transfer to produce low-immunogenicity donor pigs within designated pathogen-free facilities, enabling medical institutions to access transplantable porcine kidneys, livers, hearts, skin and disease models for clinical applications.

Contact Information

Website
www.clonorgan.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 11, 3rd Floor, Building 1A, No. 1480, Tianfu Avenue North Section
  • Chengdu Hi-tech Zone, China Pilot Free Trade Zone
  • Chengdu, Sichuan 610041
  • China
+86 028
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Room 11, 3rd Floor, Building 1A, No. 1480, Tianfu Avenue North Section
  • Chengdu Hi-tech Zone, China Pilot Free Trade Zone
  • Chengdu, Sichuan 610041
  • China
+86 028

ClonOrgan Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ClonOrgan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A3) 07-Aug-2026 $29.5M Completed Generating Revenue
5. Later Stage VC (Series A2) 04-Sep-2025 Completed Generating Revenue
4. Later Stage VC (Series A1) 19-Jun-2024 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Sep-2021 Completed Generating Revenue
2. Early Stage VC 29-Dec-2020 Completed Generating Revenue
1. Seed Round 12-Oct-2018 Completed Startup
To view ClonOrgan’s complete valuation and funding history, request access »

ClonOrgan Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

ClonOrgan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4803625-A1 Method for constructing genetically-engineered animal used for xenotransfusion Pending 03-Nov-2023
WO-2025091694-A1 Method for constructing genetically-engineered animal used for xenotransfusion Inactive 03-Nov-2023

ClonOrgan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ClonOrgan Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
CAS Star Venture Capital Minority
Chengdu Venture Capital Group Venture Capital Minority
Guanghe Venture Venture Capital Minority
Hangzhou Huafang Chuanghuang Investment Management Corporate Venture Capital Minority
Holley Group Corporation Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

ClonOrgan FAQs

  • When was ClonOrgan founded?

    ClonOrgan was founded in 2018.

  • Where is ClonOrgan headquartered?

    ClonOrgan is headquartered in Chengdu, China.

  • What is the size of ClonOrgan?

    ClonOrgan has 30 total employees.

  • What industry is ClonOrgan in?

    ClonOrgan’s primary industry is Biotechnology.

  • Is ClonOrgan a private or public company?

    ClonOrgan is a Private company.

  • What is ClonOrgan’s current revenue?

    The current revenue for ClonOrgan is .

  • How much funding has ClonOrgan raised over time?

    ClonOrgan has raised $37.9M.

  • Who are ClonOrgan’s investors?

    CAS Star, Chengdu Venture Capital Group, Guanghe Venture, Hangzhou Huafang Chuanghuang Investment Management, and Holley Group are 5 of 13 investors who have invested in ClonOrgan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process